Randomized, double-blind, placebo controlled trial on the efficacy of montelukast in exercise-induced asthma in children - MONTEIA
- Conditions
- exercise-induced asthmaMedDRA version: 6.1Level: PTClassification code 10003557
- Registration Number
- EUCTR2005-004984-43-IT
- Lead Sponsor
- IVERSITA DEGLI STUDI DI UDINE
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- All
- Target Recruitment
- 22
Inclusion Criteria
outpatients aged 6 to 14 years with a history of typical symptoms of exercise-induced asthma. pre-exercise FEV1 at least 75 of the predicted value 15 or greater decrease in FEV1 after a standardized treadmill exercise challenge Absence of farmacological treatment
Are the trial subjects under 18? yes
Number of subjects for this age range:
F.1.2 Adults (18-64 years) no
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range
Exclusion Criteria
Sensitivity to montelukast Singulair or its components. a pulmonary disease other than asthma or other cronic pathologies acute upper respiratory tract infection
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method